Citigroup Maintains Neutral on Bruker, Lowers Price Target to $53

Benzinga Newsdesk www.benzinga.com Negative 74.9%

Neg 74.9% Neu 0% Pos 0%

Citigroup analyst Brendan Digan maintains Bruker (NASDAQ:BRKR) with a Neutral and lowers the price target from $60 to $53.